July 11, 2024 || Jeff Hall
The “People in Plant” (PiP) program is pivotal in recognizing and enhancing the contributions of employees in a pharmaceutical manufacturing facility. Implementing such a comprehensive initiative requires specialized expertise, strategic planning, and a nuanced understanding of both human resources and the pharmaceutical industry. This is where consultants play a crucial…
June 18, 2024 || Robert Ossig
Unlocking the Future: Exploring Cutting-Edge Cell and Gene Therapies The world of medicine is in the middle of a transformative evolution following the advent of cell and gene therapies. These cutting-edge treatments offer promising avenues for tackling diseases at their root causes, providing hope for conditions that were previously deemed…
June 11, 2024 || Robert Ossig
In the complex landscape of pharmaceutical and biopharmaceutical product development, the initiation stage of technology transfer (TT) is critical for ensuring successful scale-up and manufacturing. This stage involves a multidisciplinary approach, where business, technical, and regulatory considerations must be meticulously assessed to determine the feasibility and strategy for TT. Effective…
